LABCORP HOLDINGS INC. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Restructuring Charges, Percent
LABCORP HOLDINGS INC. (LH) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Restructuring Charges, Percent of 0.00% for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-25.
Discontinued › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges · last filed 2022-02-25
- LABCORP HOLDINGS INC. effective income tax rate reconciliation, nondeductible expense, restructuring charges, percent for the quarter ending 2016-03-31 was 0.00%, a 100.00% decline year-over-year.
- LABCORP HOLDINGS INC. effective income tax rate reconciliation, nondeductible expense, restructuring charges, percent for the quarter ending 2015-03-31 was 2.70%.
- LABCORP HOLDINGS INC. effective income tax rate reconciliation, nondeductible expense, restructuring charges, percent for the quarter ending 2014-03-31 was 0.00%.
- LABCORP HOLDINGS INC. effective income tax rate reconciliation, nondeductible expense, restructuring charges, percent for fiscal 2021 was 0.00%.
- LABCORP HOLDINGS INC. effective income tax rate reconciliation, nondeductible expense, restructuring charges, percent for fiscal 2020 was 0.00%, a 100.00% decline from fiscal 2019.
- LABCORP HOLDINGS INC. effective income tax rate reconciliation, nondeductible expense, restructuring charges, percent for fiscal 2019 was 0.70%, a 63.16% decline from fiscal 2018.
- LABCORP HOLDINGS INC. effective income tax rate reconciliation, nondeductible expense, restructuring charges, percent for fiscal 2018 was 1.90%, a 216.67% increase from fiscal 2017.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Restructuring Charges, Percent 3 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Restructuring Charges, Percent 12 month |
|---|---|---|
| 2021-12-31 | 0.00% 10-K · filed 2022-02-25 | |
| 2020-12-31 | 0.00% 10-K · filed 2022-02-25 | |
| 2019-12-31 | 0.70% 10-K · filed 2022-02-25 | |
| 2018-12-31 | 1.90% 10-K · filed 2021-02-25 | |
| 2017-12-31 | 0.60% 10-K · filed 2020-02-28 | |
| 2016-12-31 | 0.00% 10-K · filed 2019-02-28 | |
| 2016-03-31 | 0.00% 10-K · filed 2018-02-27 | |
| 2015-12-31 | 2.70% 10-K · filed 2017-02-27 | |
| 2015-03-31 | 2.70% 10-K · filed 2018-02-27 | |
| 2014-12-31 | 0.00% 10-K · filed 2016-03-01 | |
| 2014-03-31 | 0.00% 10-K · filed 2017-02-27 | |
| 2013-12-31 | 0.00% 10-K · filed 2016-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |